Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform
Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...
News Medical3d
Emerging antibiotics at risk of resistance before clinical use
Researchers from the HUN-REN Biological Research Centre, Szeged (Hungary), have made a concerning discovery about the future of antibiotics.
Long-COVID patients are frustrated that federal research hasn’t found new treatments
Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.
Taiwan News5d
Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Azenosertib Clinical Results ZN-c3-001 ZN-c3-001 is a Phase 1, dose-escalation study that evaluated azenosertib monotherapy in solid tumors across continuous and intermittent dosing schedules.